Lv5
1020 积分 2022-09-07 加入
Cagrilintide–semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study
17天前
已完结
Targeting ATR in patients with cancer
3个月前
已完结
DE-310, a macromolecular prodrug of the topoisomerase-I-inhibitor exatecan (DX-8951), in patients with operable solid tumors
3个月前
已完结
Advances in the Quest for Safe and Effective Drugs That Target the Cannabinoid Receptor Type 1 (CB1)
3个月前
已完结
Structural and Functional Insights into Cannabinoid Receptors
3个月前
已完结
β-Arrestin2 Regulates Cannabinoid CB1 Receptor Signaling and Adaptation in a Central Nervous System Region–Dependent Manner
3个月前
已完结
Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery
3个月前
已完结
Rational design of Gi-biased CB1 agonist with reduced side effects
3个月前
已完结
Rational design of Gi-biased CB1 agonist with reduced side effects
3个月前
已完结
Discovery of Non-Carboxylic Steroidal FXR Agonist as a Promising Preclinical Candidate for Metabolic Dysfunction-Associated Steatohepatitis
3个月前
已完结
皖公网安备34019202002308
